Atlas Trials

A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine

Clinical trial NCT06465420 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06465420
Sponsor
InventVacc Biologicals Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Haemophilus Influenzae MeningitisInvasive Haemophilus Influenzae Disease
Start date
2024-05-29
Primary completion
2024-10-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.